JasonH.RogersMD
Cardiology • Sacramento, CAAdult Congenital Heart Disease, Interventional Cardiology
Associate Professor, Internal Medicine, UC, Davis School of Medicine
Are you Dr. Rogers?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4860 Y St
Suite 2820
Sacramento, CA 95817Phone+1 916-734-3764Fax+1 916-734-8394
Summary
- Dr. Jason Rogers, MD is a cardiologist in Sacramento, California. He is currently licensed to practice medicine in California. He is an Associate Professor at UC.
Education & Training
Saint Louis University School of MedicineClass of 1995
Certifications & Licensure
CA State Medical License 2003 - 2026- CA State Medical License 2003 - 2026
American Board of Internal Medicine Cardiovascular Disease- American Board of Internal Medicine Interventional Cardiology
Publications & Presentations
PubMed
- Residual Mitral Regurgitation Interacts With Transmitral Mean Pressure Gradient to Modify the Association With Mortality Following Transcatheter Edge-to-Edge Repair.Neal M Duggal, Milo Engoren, Paul Sorajja, D Scott Lim, Jason H Rogers
Circulation. Cardiovascular Interventions. 2025-02-01 - 2 citationsEvaluating Mitral TEER in the Management of Moderate Secondary Mitral Regurgitation Among Heart Failure Patients.Anita W Asgar, Gilbert H L Tang, Jason H Rogers, Wolfgang Rottbauer, M Andrew Morse
JACC. Heart Failure. 2025-02-01 - 5 citationsStructural Heart Imaging Using 3-Dimensional Intracardiac Echocardiography: JACC: Cardiovascular Imaging Position Statement.Gilbert H L Tang, Syed Zaid, Rebecca T Hahn, Vratika Aggarwal, Mohamad Alkhouli
JACC. Cardiovascular Imaging. 2025-01-01
Press Mentions
MitraClip and TriClip TEER Devices Continue to Show Positive ResultsSeptember 21st, 2022- Data Reinforces Value of Abbott MitraClip for Treating MRSeptember 17th, 2022
- Late-Breaking Data Show Breadth of Abbott's Minimally Invasive Structural Heart TechnologiesSeptember 17th, 2022
- Join now to see all
